Nanosilver no ‘silver bullet’ in long-term treatment of infections
New research has found that pathogens that form biofilms can evolve to survive nanosilver treatment. The study is the first to demonstrate that long-term nanosilver treatment can increase the risk of recurrent infections.
Read Original Article: Nanosilver no ‘silver bullet’ in long-term treatment of infections »
